The results of your word search

Mega Pharmaceutical Astellas Pharma Kicks Off Operations (Apr 1, 2005)

Fujisawa Pharmaceutical to Outsource Cefzon Bulk Production to API Corporation (Mar 25, 2005)

Fujisawa Pharmaceutical to Contract Out Home Healthcare Business to Teijin Pharma (Mar 7, 2005)

Fujisawa Pharmaceutical, Carlsson Research Conclude Licensing Agreement for Antipsychotic Agent ACR-16 (Feb 8, 2005)

Yamanouchi to Spin Off Formulation Plants (Nov 10, 2004)

Yamanouchi Pharmaceutical, Fujisawa Pharmaceutical Develop Business Philosphy, Logo, and Corporate Messages for Their Merging Entity Astellas (Sept 16, 2004)

Fujisawa Pharmaceutical Revised List of Ethical Drug Products Currently Under Development (Feb 27, 2004)

Yamanouchi and Fujisawa to Merge (Feb 24, 2004)

Fujisawa Pharmaceutical Licenses Drug-coated Stents to JOMED (Dec 20, 2001)

Fujisawa Completes Construction of New Formulation Facilities for Micafungin (Aug 3, 2004)

Fujisawa and Yamanouchi Will Establish Zepharma Inc., an OTC Pharmaceutical Company (May 17, 2004)

Fujisawa Enters Collaborative Research with Pharmagenesis (Sept 20, 2002)

Fujisawa Licenses Rights to Tacrolimus-eluting Stents to Sorin Biomedica (Sept 19, 2002)

Fujisawa to Allocate Research Grants to Commemorate the 30th Anniversary of its Medical Supply Business Inauguraton (Sept 9, 2002)

Fujisawa Implements Measures Reinforcing the Japanese Business and Revises Its Financial Forecast for the Fiscal Year Ending March 2003 (Sept 4, 2002)

Fujisawa Invests US $ 8 Million in Sucampo Pharmaceuticals (Aug 9, 2002)

Fujisawa Licenses Marketing Rights to Cefzon in China to Xian-Janssen (July 10, 2002)

The Fujisawa Foundation Allocates Research Grants (July 1, 2002)

Fujisawa will Launch New CalciChew Brand Products (May 21, 2002)